Brief: Galecto Inc Hans T. Schambye To Cease Serving As CEO And President
10/02/2026 14:05
Feb 10 (Reuters) - Galecto Inc GLTO.O: GALECTO INC - HANS T. SCHAMBYE TO CEASE SERVING AS CEO AND PRESIDENT - SEC FILING GALECTO INC - SHERWIN SATTARZADEH APPOINTED INTERIM PRINCIPAL EXECUTIVE OFFICER - SEC FILING Source text: [ID:n0001193125-26-043741] Further company coverage: GLTO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing